Breast Cancer Update

Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

Mar 26, 2024
Guest
Seth Wander
Dr Seth Wander from Harvard Medical School discusses overcoming endocrine resistance in ER-positive metastatic breast cancer. Topics include ESR1 mutations, efficacy of drugs like chamazestrant, molecular biology, precision medicine, and advancements in endocrine therapy.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 4min
2
Understanding ESR1 Mutations in Resistance to Anti-Estrogens
04:20 • 25min
3
Exploring Drug Efficacy in ER-Positive Metastatic Breast Cancer
29:05 • 18min
4
Exploring Efficacy, Toxicity, and Targeted Therapies in Breast Cancer: Insights from Clinical Trials
46:38 • 4min
5
Precision Medicine in ER-Positive Metastatic Breast Cancer
50:20 • 6min
6
Advancements in Endocrine Therapy for ER-Positive Breast Cancer
55:55 • 21min
7
The Significance of Next-Generation Sequencing in Metastatic ER-Positive Breast Cancer Management
01:16:36 • 3min